Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline

A long-term trial with oral pentoxifylline ("Trental" 400) in a dosage of 1200 mg per day was carried out in 70 diabetic patients with and without vascular afflictions. A statistically significant improvement in erythrocyte filtrability and a statistically significant reduction in fibrinog...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 4(1985), 6 vom: 30., Seite 341-50
1. Verfasser: Solerte, S B (VerfasserIn)
Weitere Verfasser: Ferrari, E
Format: Aufsatz
Sprache:English
Veröffentlicht: 1985
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Journal Article Blood Glucose Glycated Hemoglobin A Fibrinogen 9001-32-5 Theobromine OBD445WZ5P Pentoxifylline SD6QCT3TSU